Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Thrombocytopenia
Interventions: DRUG: Romiplostim|DRUG: Placebo
Sponsor: Amgen